- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 5.21M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 3.77M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 1.83M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $0 |
| Capex | Q1 2026 · Mar 31, 2025 | $43K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.36M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$5.28M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $1.48M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $4.89M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.6M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $6.16M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $2.35M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | $2.74M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $1.83M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $1.76M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $3.34M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.46M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $2.91M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $6.35M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $5.94M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $9.62M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.33 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$2.71 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.33 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$2.71 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.12M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.75M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $2.95M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.78M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$5M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$4.97M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$5.07M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$4.53M |